Source:http://linkedlifedata.com/resource/pubmed/id/20559842
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2010-11-10
|
pubmed:abstractText |
Intravenous thrombolysis leads to a reduction of post-stroke disability. No data exist about whether depression and poor quality of life (QoL) remain relevant problems in patients with good functional outcome. We assessed mood and QoL at 3 and 6 months after stroke in consecutive patients who received intravenous thrombolysis in stroke centers and telemedicine hospitals within the TEMPiS network. The Beck Depression Inventory (BDI) was used with BDI ?18 indicating clinically relevant depressive symptoms. Stroke specific quality of life (SSQOL) was used for QoL assessment with the definition of SSQOL total score <60% for poor QoL. Associations of BDI and SSQOL with baseline parameters and modified Rankin scale (mRS) in follow-up were analyzed. In patients with known mRS 0-4 at 3 months (N = 213), BDI was available in 74% and SSQOL in 77%. At 3 and 6 months, 23 and 18% of patients had clinically relevant depressive symptoms; 25 and 24% reported a poor QoL. The mRS at 3 months correlated with BDI (r = 0.43, p < 0.01) and SSQOL (r = -0.75, p < 0.01). BDI ?18 was observed in 11% of patients with mRS 0-1 and 16% in mRS 0-2. Severe stroke (NIHSS ?12) at admission (OR 1.23, 0.57-2.66; p = 0.57) was not predictive for depressive symptoms but for poor QoL (OR 2.77, 95%CI 1.34-5.74). Depressive symptoms and impaired QoL are observed in a substantial proportion of stroke patients at 3 months after intravenous thrombolysis. Health professionals should be aware that thrombolysed patients may have relevant mood disorders despite good functional outcome.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1432-1459
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
257
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1848-54
|
pubmed:meshHeading |
pubmed-meshheading:20559842-Aged,
pubmed-meshheading:20559842-Depression,
pubmed-meshheading:20559842-Female,
pubmed-meshheading:20559842-Humans,
pubmed-meshheading:20559842-Male,
pubmed-meshheading:20559842-Prevalence,
pubmed-meshheading:20559842-Quality of Life,
pubmed-meshheading:20559842-Recovery of Function,
pubmed-meshheading:20559842-Stroke,
pubmed-meshheading:20559842-Thrombolytic Therapy
|
pubmed:year |
2010
|
pubmed:articleTitle |
Depressive symptoms and quality of life after thrombolysis in stroke: the TEMPiS study.
|
pubmed:affiliation |
Department of Neurology, University and University Hospital of Regensburg, Regensburg, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|